Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a minor revision update: Revision: v3.4.2 added and Revision: v3.4.1 removed, with no changes to core trial details or layout evident in the screenshot. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedA revision tag was updated to v3.4.1 (replacing v3.4.0), a metadata change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page adds a 'Show glossary' option and updates metadata labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', along with capitalization adjustments for 'No FEAR Act Data'. The old labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4') were removed or updated.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; this is a minor UI/version update on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a dedicated 'Locations' section with Alberta and Ontario listings. Removed separate 'Alberta Locations' and 'Ontario Locations' references and updated the page footer to Revision: v3.3.3.SummaryDifference0.4%

- Check89 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.